19.52
Schlusskurs vom Vortag:
$19.24
Offen:
$19.19
24-Stunden-Volumen:
182.67K
Relative Volume:
0.53
Marktkapitalisierung:
$791.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-136.98M
KGV:
-4.8557
EPS:
-4.02
Netto-Cashflow:
$-126.63M
1W Leistung:
+1.61%
1M Leistung:
+3.94%
6M Leistung:
-11.09%
1J Leistung:
-25.27%
Arrivent Biopharma Inc Stock (AVBP) Company Profile
Firmenname
Arrivent Biopharma Inc
Sektor
Branche
Telefon
240-780-6356
Adresse
18 CAMPUS BLVD., NEWTOWN SQUARE
Vergleichen Sie AVBP mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
AVBP
Arrivent Biopharma Inc
|
19.52 | 804.89M | 0 | -136.98M | -126.63M | -4.02 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Arrivent Biopharma Inc Stock (AVBP) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-07-10 | Fortgesetzt | Goldman | Buy |
2025-03-20 | Eingeleitet | B. Riley Securities | Buy |
2025-03-10 | Eingeleitet | Guggenheim | Buy |
2024-07-22 | Eingeleitet | Oppenheimer | Outperform |
2024-04-30 | Eingeleitet | H.C. Wainwright | Buy |
2024-02-20 | Eingeleitet | Citigroup | Buy |
2024-02-20 | Eingeleitet | Goldman | Buy |
2024-02-20 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Arrivent Biopharma Inc Aktie (AVBP) Neueste Nachrichten
Institutional scanner results for ArriVent BioPharma Inc.July 2025 Short Interest & Verified High Yield Trade Plans - Newser
Will ArriVent BioPharma Inc. benefit from macro trendsBond Market & AI Driven Price Forecasts - Newser
Real time breakdown of ArriVent BioPharma Inc. stock performanceWeekly Stock Recap & Real-Time Market Sentiment Alerts - Newser
Is ArriVent BioPharma Inc. showing signs of accumulation2025 Year in Review & Reliable Entry Point Trade Alerts - Newser
Published on: 2025-09-04 00:41:04 - Newser
Published on: 2025-09-04 08:31:42 - khodrobank.com
Smart tools for monitoring ArriVent BioPharma Inc.’s price actionQuarterly Growth Report & Long-Term Capital Growth Ideas - Newser
Advanced analytics toolkit walkthrough for ArriVent BioPharma Inc.Analyst Downgrade & Risk Managed Trade Strategies - Newser
Does ArriVent BioPharma Inc. have pricing power2025 Buyback Activity & Precise Trade Entry Recommendations - khodrobank.com
Can ArriVent BioPharma Inc. hit a new high this month2025 Volume Leaders & High Conviction Investment Ideas - Newser
Historical volatility pattern of ArriVent BioPharma Inc. visualizedMarket Movement Recap & Safe Entry Momentum Tips - Newser
Institutional Tools Highlight Unusual Flow in ArriVent BioPharma Inc.July 2025 Movers & Weekly Breakout Stock Alerts - beatles.ru
Earnings visualization tools for ArriVent BioPharma Inc.Fed Meeting & Technical Confirmation Alerts - Newser
Is this a good reentry point in ArriVent BioPharma Inc.Quarterly Portfolio Review & High Conviction Buy Zone Alerts - Newser
Nuveen LLC Takes $819,000 Position in ArriVent BioPharma, Inc. $AVBP - Defense World
Regression analysis insights on ArriVent BioPharma Inc. performanceMarket Rally & High Conviction Buy Zone Alerts - Newser
How high can ArriVent BioPharma Inc. stock goDip Buying & Free Fast Entry Momentum Trade Alerts - Newser
Will ArriVent BioPharma Inc. outperform the marketJuly 2025 PreEarnings & Precise Swing Trade Entry Alerts - Newser
Will breakout in ArriVent BioPharma Inc. lead to full recoveryEntry Point & Stock Market Timing Techniques - Newser
Understanding ArriVent BioPharma Inc.’s price movement2025 Price Momentum & Scalable Portfolio Growth Methods - Newser
What to expect from ArriVent BioPharma Inc. in the next 30 daysJuly 2025 Fed Impact & Precise Buy Zone Tips - Newser
Is now a turning point for SmartKem Inc.July 2025 Market Mood & Breakout Confirmation Alerts - Newser
Published on: 2025-09-02 03:06:28 - Newser
Watch for Bullish Crossover in ArriVent BioPharma Inc. getLinesFromResByArray error: size == 0 - 강소기업뉴스
Analyzing recovery setups for ArriVent BioPharma Inc. investors2025 Dividend Review & Community Consensus Trade Signals - Newser
What recovery options are there for ArriVent BioPharma Inc.July 2025 Trade Ideas & Weekly High Conviction Trade Ideas - Newser
Full technical analysis of ArriVent BioPharma Inc. stock2025 Breakouts & Breakdowns & Verified Entry Point Detection - Newser
Automated trading signals detected on ArriVent BioPharma Inc.Portfolio Performance Report & Consistent Profit Focused Trading Strategies - Newser
Risk adjusted return profile for ArriVent BioPharma Inc. analyzedPortfolio Update Summary & Proven Capital Preservation Methods - Newser
Volatility clustering patterns for ArriVent BioPharma Inc.2025 Short Interest & Safe Swing Trade Setup Alerts - Newser
Will ArriVent BioPharma Inc. stock go up soonMarket Growth Review & Low Risk High Reward Ideas - Newser
ArriVent BioPharma Inc. stock prediction for this weekStop Loss & Free Weekly Watchlist of Top Performers - Newser
What machine learning models say about ArriVent BioPharma Inc.July 2025 Movers & Breakout Confirmation Trade Signals - Newser
Finanzdaten der Arrivent Biopharma Inc-Aktie (AVBP)
Umsatz
Nettogewinn
Free Cashflow
ENV
Arrivent Biopharma Inc-Aktie (AVBP) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
LaChapelle Robin | Chief Operating Officer |
Sep 19 '24 |
Option Exercise |
3.28 |
27,566 |
90,481 |
124,583 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):